FCN2 and plasma cell myeloma: Both papers documented possible associations of factors specific for the lectin pathway of complement (especially on genetic background) with multiple myeloma or lymphoma (MBL, ficolin-1, ficolin-2) or hospital infections (MASP-2, ficolin-3).